Diagnostic value of CAR, HALP, and SII for predicting complicated appendicitis: a reassessment of inflammatory indices

CAR、HALP 和 SII 在预测复杂性阑尾炎中的诊断价值:炎症指标的重新评估

阅读:1

Abstract

OBJECTIVE: Differentiating complicated from uncomplicated appendicitis remains a clinical challenge despite major advances in diagnostic imaging and evaluation. Inflammatory biomarkers derived from routine blood tests offer a practical and cost-effective tool for early risk stratification. This study aimed to reassess the diagnostic performance of the C-reactive protein-to-albumin ratio (CAR), hemoglobin–albumin–lymphocyte–platelet (HALP) score, and systemic immune-inflammation index (SII) in predicting complicated appendicitis. MATERIALS AND METHODS: A retrospective analysis was performed on 1,767 adult patients who underwent appendectomy. Patients were categorized as having complicated or uncomplicated appendicitis based on operative and histopathologic findings. Inflammatory indices were calculated, and diagnostic performance was assessed using receiver operating characteristic (ROC) analysis. Independent predictors were identified through multivariate logistic regression. RESULTS: CAR demonstrated the highest diagnostic performance among the evaluated indices, with an AUC of 0.713, significantly outperforming HALP and SII. Using a cutoff greater than 21.55, CAR achieved a specificity of 94.4% and was strongly associated with complicated appendicitis (odds ratio, 12.58). Multivariate analysis confirmed CAR and patient age as independent predictors. CONCLUSION: CAR is a reliable and clinically useful diagnostic biomarker compared to other evaluated inflammatory indices for predicting complicated appendicitis. However, its relatively low sensitivity suggests limited utility as a standalone screening tool, and CAR should therefore be interpreted alongside clinical and imaging findings in routine practice.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。